Heart failure: advances through genomics (original) (raw)

• Hunt, S. A. et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119, e391–e479 (2009).
  PubMed Google Scholar
• Creemers, E. E. & Pinto, Y. M. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc. Res. 89, 265–272 (2010).
  Article PubMed Google Scholar
• Swynghedauw, B. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79, 215–262 (1999).
  Article CAS PubMed Google Scholar
• Benjamin, I. J. & Schneider, M. D. Learning from failure: congestive heart failure in the postgenomic age. J. Clin. Invest. 115, 495–499 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Mudd, J. O. & Kass, D. A. Tackling heart failure in the twenty-first century. Nature 451, 919–928 (2008).
  Article CAS PubMed Google Scholar
• Lee, D. S. et al. Association of parental heart failure with risk of heart failure in offspring. N. Engl. J. Med. 355, 138–147 (2006).
  Article CAS PubMed Google Scholar
• Smith, N. L. et al. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Circ. Cardiovasc. Genet. 3, 256–266 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Morrison, A. C. et al. Genomic variation associated with mortality among adults of European and african ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium. Circ. Cardiovasc. Genet. 3, 248–255 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Vasan, R. S. et al. Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA 302, 168–178 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Cappola, T. P. et al. Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation. Proc. Natl Acad. Sci. USA 108, 2456–2461 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Hershberger, R. E. et al. Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline. J. Card. Fail. 15, 83–97 (2009).
  Article PubMed Google Scholar
• van der Zwaag, P. A. et al. One mutation fits all: phospolamban R14del causes both dilated cardiomypathy and arrhytmogenic right ventricular cardiomyopathy/dysplasia. Circulation 122, A17663 (2010).
  Google Scholar
• van Spaendonck-Zwarts, K. Y. et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 121, 2169–2175 (2010).
  Article PubMed Google Scholar
• Ng, S. B. et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nature Genet. 42, 790–793 (2010).
  Article CAS PubMed Google Scholar
• Zhang, C. L. et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479–488 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Movassagh, M. et al. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS ONE 5, e8564 (2010).
  Article PubMed PubMed Central Google Scholar
• Yi, P., Han, Z., Li, X. & Olson, E. N. The mevalonate pathway controls heart formation in Drosophila by isoprenylation of Gγ1. Science 313, 1301–1303 (2006).
  Article CAS PubMed Google Scholar
• Milan, D. J. et al. Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation 120, 553–559 (2009).
  Article PubMed PubMed Central Google Scholar
• Lowes, B. D. et al. Myocardial gene expression in dilated cardiomyopathy treated with β-blocking agents. N. Engl. J. Med. 346, 1357–1365 (2002).
  Article CAS PubMed Google Scholar
• Knollmann, B. C. & Roden, D. M. A genetic framework for improving arrhythmia therapy. Nature 451, 929–936 (2008).
  Article CAS PubMed Google Scholar
• Nanni, L., Romualdi, C., Maseri, A. & Lanfranchi, G. Differential gene expression profiling in genetic and multifactorial cardiovascular diseases. J. Mol. Cell. Cardiol. 41, 934–948 (2006).
  Article CAS PubMed Google Scholar
• Hwang, J. J. et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol. Genomics 10, 31–44 (2002).
  Article CAS PubMed Google Scholar
• Schroen, B. et al. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ. Res. 95, 515–522 (2004).
  Article CAS PubMed Google Scholar
• Schroen, B. et al. Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy. J. Exp. Med. 204, 1227–1235 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• van Kimmenade, R. R. et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J. Am. Coll. Cardiol. 48, 1217–1224 (2006).
  Article CAS PubMed Google Scholar
• Matkovich, S. J., Zhang, Y., Van Booven, D. J. & Dorn, G. W. Deep mRNA sequencing for in vivo functional analysis of cardiac transcriptional regulators: application to Gαq. Circ. Res. 106, 1459–1467 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Creemers, E. E., Sutherland, L. B., Oh, J., Barbosa, A. C. & Olson, E. N. Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR. Mol. Cell 23, 83–96 (2006).
  Article CAS PubMed Google Scholar
• Kong, S. W. et al. Heart failure-associated changes in RNA splicing of sarcomere genes. Circ. Cardiovasc. Genet. 3, 138–146 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Neagoe, C. et al. Titin isoform switch in ischemic human heart disease. Circulation 106, 1333–1341 (2002).
  Article PubMed Google Scholar
• Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature Biotech. 28, 511–515 (2010).
  Article CAS Google Scholar
• Kleinjan, D. A. & van Heyningen, V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am. J. Hum. Genet. 76, 8–32 (2005).
  Article CAS PubMed Google Scholar
• Blow, M. J. et al. ChIP-Seq identification of weakly conserved heart enhancers. Nature Genet. 42, 806–810 (2010).
  Article CAS PubMed Google Scholar
• Haberland, M., Montgomery, R. L. & Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nature Rev. Genet. 10, 32–42 (2009).
  Article CAS PubMed Google Scholar
• Rakyan, V. K. & Beck, S. Epigenetic variation and inheritance in mammals. Curr. Opin. Genet. Dev. 16, 573–577 (2006).
  Article CAS PubMed Google Scholar
• Esteller, M. Epigenetics in cancer. N. Engl. J. Med. 358, 1148–1159 (2008).
  Article CAS PubMed Google Scholar
• Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980–984 (2008).
  Article CAS PubMed Google Scholar
• Care, A. et al. MicroRNA-133 controls cardiac hypertrophy. Nature Med. 13, 613–618 (2007).
  Article CAS PubMed Google Scholar
• Small, E. M., Frost, R. J. & Olson, E. N. MicroRNAs add a new dimension to cardiovascular disease. Circulation 121, 1022–1032 (2010).
  Article PubMed PubMed Central Google Scholar
• van Rooij, E. et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575–579 (2007).
  Article CAS PubMed Google Scholar
• Elmen, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896–899 (2008).
  Article CAS PubMed Google Scholar
• Tijsen, A. J. et al. MiR423–425p as a circulating biomarker for heart failure. Circ. Res. 106, 1035–1039 (2010).
  Article CAS PubMed Google Scholar
• Clop, A. et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nature Genet. 38, 813–818 (2006).
  Article CAS PubMed Google Scholar
• Kasowski, M. et al. Variation in transcription factor binding among humans. Science 328, 232–235 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Dorn, G. W. Pharmacogenetic profiling in the treatment of heart disease. Transl. Res. 154, 295–302 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Johnson, J. A. & Liggett, S. B. Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions. Clin. Pharmacol. Ther. 89, 366–378 (2011).
  Article CAS PubMed Google Scholar
• Brugts, J. J. et al. Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. Eur. Heart J. 31, 1854–1864 (2010).
  Article CAS PubMed Google Scholar
• Sakuntabhai, A. et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nature Genet. 21, 271–277 (1999).
  Article CAS PubMed Google Scholar
• Mayosi, B. M. et al. Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure. Heart 92, 105–109 (2006).
  Article CAS PubMed Google Scholar
• Shull, G. E. et al. Physiological functions of plasma membrane and intracellular Ca2+ pumps revealed by analysis of null mutants. Ann. N. Y. Acad. Sci. 986, 453–460 (2003).
  Article CAS PubMed Google Scholar